Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-21-029359

EVP and CFO sold 1,032 shares at $20.33 ($20,981)

  • EVP and CFO acquired 3,245 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ridloff Elena · EVP and CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-04-29 Exercise or conversion : show line 1 in the form +3,245 11,585 D
2021-04-30 Sale : show line 2 in the form −1,032 $20.33 $20,981 10,553 D
Open-market sales · 1,032 sh · avg $20.33 · $20,981

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-04-29 Exercise or conversion : show line 3 in the form Restricted Stock Units −3,245 6,491 D
Loading xslF345X03/doc4.xml…